|
WO2020252522A1
|
|
Antibacterial dosage regime using cannabinoids
|
|
WO2020000024A1
|
|
Antibacterial treatment using cannabinoid combinations
|
|
US2019224137A1
|
|
Cannabinoid Dosing Regime for Acne
|
|
AU2019210704A1
|
|
Cannabinoid dosing regime for psoriasis
|
|
US2021059961A1
|
|
Cannabinoid dosing regime for acne
|
|
AU2019210703A1
|
|
Cannabinoid dosing regime for dermatitis and inflammatory skin conditions
|
|
US2020289430A1
|
|
Antibacterial Treatments Using Cannabinoids
|
|
WO2018148795A1
|
|
Compositions for treating acne
|
|
EP3582763A1
|
|
Compositions for treating acne
|
|
AU2018221881A1
|
|
Formulations of cannabinoids for the treatment of acne
|
|
WO2018148786A1
|
|
Formulations of cannabinoids for the treatment of acne
|
|
CN110520123A
|
|
For treating the cannabinoid formulation of psoriasis
|
|
WO2018148785A1
|
|
Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
|
|
CA3053500A1
|
|
Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
|
|
WO2018148787A1
|
|
Formulations of cannabinoids for the treatment of psoriasis
|
